T2 Biosystems has announced its preliminary financial results for the third quarter of 2024. The MedTech sector is closely watching these results as they provide insights into the company's performance during what has been described as a volatile quarter. Investors are also anticipating the upcoming earnings preview for MedTech stocks, which is expected to shed light on the sector's overall health going into the fourth quarter of 2024. T2 Biosystems' stock symbol is $TTOO.